Older men who undergo testosterone-suppressing therapy to treat prostate cancer may experience a higher risk of developing clinical depression later in life. This risk seems to increase the longer they stay on the therapy, a new study says.
Older men who undergo testosterone-suppressing therapy to treat prostate cancer may experience a higher risk of developing clinical depression later in life. This risk seems to increase the longer they stay on the therapy, a new study says.
Share this Article
Recommended